Kids Disease Child Disease Encyclopedia
Illustration representing Erythema Infectiosum (Fifth Disease)
Mild Systemic Contagious Viral Exanthems

Erythema Infectiosum (Fifth Disease)

Parvovirus-Induced Exanthem

Primary risk age: 4 to 10 Years

Urgency
Mild
Typical age
4 to 10 Years
Body system
Infectious & Parasitic

Typical course: 7 to 21 days.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Parvovirus-Induced Exanthem

Pathophysiology (Development Path)

Parvovirus B19 infects erythrocyte progenitor cells in the bone marrow. The rash is immune-mediated, presenting once viremia clears.

Primary Causes & Etiology

Human Parvovirus B19.

2. Symptom Continuum

  1. Early Onset Signs

    Mild low-grade fever, headache, rhinorrhea, and mild joint pain.

  2. Progressive Phase

    Bright red rash on the cheeks ('slapped cheek' appearance) appearing 2-5 days after initial symptoms, followed by a reticulated (lace-like) maculopapular rash on the trunk and extremities.

  3. Severe Indicators

    Aplastic crisis in children with sickle cell anemia or spherocytosis, severe arthropathy, and chronic anemia.

3. Clinical Verification

Clinical diagnosis based on the classic slapped-cheek rash. IgM antibody testing can confirm infection.

4. Care & Elements Plan

Primary Care Treatment Plan

Supportive care. Pain management for joint pain if present.

Home Support Elements

Encourage rest and fluids. Avoid hot baths or sunlight, which can cause the rash to flare up.

Generic Active Ingredients (No Brands)

  • Ibuprofen or Acetaminophen (for fever and joint pain).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Seek medical assessment if the child has sickle cell anemia or a compromised immune system and develops a fever.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

Frequent handwashing. Avoid sharing utensils.

Immunization Context

No vaccine available.

7. Timelines & Outlook

Active Timeline

7 to 21 days.

Expected Prognosis

Excellent. Self-limiting; rash resolves in 1 to 3 weeks.

Potential Untreated Complications

Transient aplastic crisis, arthropathy, fetal hydrops (risk to pregnant contacts).